About
APIs, Hyaluronic Acid Products
Areas of Focus
Categories
API FocusedUncategorized Medical Device
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
7
As Collaborator
0
Total Enrollment
720
By Phase
NA: 6PHASE4: 1
By Status
COMPLETED: 6NOT_YET_RECRUITING: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06910111Lead Sponsor
CAPTURE Study (Polyglucosamine for Cardio & Atherosclerosis Prevention and Treatment Via Fat Uptake REduction)
NANot yet recruiting
240 participants
Started: Apr 1, 2025 · Completed: Mar 31, 2027
NCT05038436Lead Sponsor
Influence of Polyglucosamine L112 on Serum Surrogate Markers of Cholesterol Absorption
NACompleted
30 participants
Started: Sep 16, 2021 · Completed: Jun 21, 2022
NCT04375696Lead Sponsor
Randomized Double Blind Placebo Controlled Clinical Trial to Evaluate Obese and Overweight Subjects
PHASE4Completed
150 participants
Started: Apr 24, 2020 · Completed: Dec 20, 2021
NCT03452085Lead Sponsor
The Artificial Saliva Spray Reduces Xerostomia in Diabetes Type II
NACompleted
21 participants
Started: Sep 23, 2017 · Completed: Jan 16, 2018
NCT02682277Lead Sponsor
Efficacy of Polyglucosamine Long Term Treatment
NACompleted
100 participants
Started: May 31, 2014 · Completed: Oct 31, 2016
Locations (1)
Headquarters
Geneva, Switzerland
Map
Loading map...